Assay

Financial-condition grades for SEC filers

Company Report · as of Oct 9, 2026


HomeCompaniesSectorsCalendarLast night

Autonomix Medical, Inc.AMIX · healthcare
GradeNonecomputable_factors_below_threshold: 3 of 14 inputs computable; 7 are required
Reliability0.76 AUCfailure model, filers with under $12.5M assets; 95% interval 0.65 to 0.86; 63 events, 2020 to 2025
Peer failure rate0.60% a yearItem 1.03 bankruptcies, same asset band, 2012 to 2025
Size bandunder $12.5M assetstotal assets $7.6M[1]
Standard universeoutsiderevenue above $1M and assets above $10M[1-2]
Warningsshort runway, thin data, degenerate inputsnot computable: dilution, distress, fortress balance sheet
Inputs computable3 of 14
Graded fromfilings received through Jun 15, 2026116 days before the rescan; every figure keyed to the SEC receipt date
Last close$3.102026-10-08; market equity $3.0M; iex feed
Price used in gradeNone
Share price, twelve months to the rescansplit-adjusted close; a lollipop at every rescan carries the letter held then; baseline ticks are SEC receipt dates of the inputs; ranges and dragging scroll the full history
$10$20NovDecJanFebMarAprMayJunJulAugSepOct$3.13
ABCDE20132014201520162017201820192020202120222023202420252026

Percentile at every rescan on file, Jan 21, 2012 to Oct 9, 2026; stronger toward the top. Hover for the date.

Open this report as it stood on

Letter setLetterPercentileBand
Jan 21, 2012nonen/a
Jun 21, 2024nonen/aQ1

Each date opens the report as it stood on that rescan.

Business, in the company's words. Opening of Item 1 of the 10-K received May 27, 2026; the document on sec.gov.

We are a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Our platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (“RF”) ablation, enabling a “sense, treat, verify” approach intended to improve the precision and consistency of nerve-targeted therapies. The technology we have developed consists of a catheter-based system incorporating a proprietary microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system.

Warnings [top]

Short runway. cash runway is 3.1 months[3]
Thin data. 3 of 14 grade factors are computable; minimum is 7
Degenerate inputs. latest revenue or assets are at or below the $100,000 validity floor[1-2]

7 checks ran; none of them enters the letter. The checks are listed on the warnings screen.

The Fourteen Inputs [top]

Lower percentile is stronger. Source numbers open the SEC filing; a range that spans filings opens the sources table.

InputPercentile, 0 to 100ValueSourcePeer medianPercentilePeersPeriod end
Profitability, sleeve percentile 8.4
Gross profitabilitynot computable32.2%
one or more required annual facts are missing
Return on invested capitalnot computable9.3%
one or more required annual facts are missing
Accruals ratio(50.9%)[1,4-6](6.6%)8.48112026-03-31
Gross margin stability, five yearsnot computable2.8 pts
five annual gross margins are required; found 0
Solvency, sleeve percentile 62.6
Twelve-month failure probabilitynot computable0.07%
four consecutive discrete net-income quarters are required; found 4
Altman Z double-prime(35.14)[1,7-12](0.31)84.17562026-03-31
Net debt to EBITDAnot computable1.82x
one or more required annual facts are missing
Interest coveragenot computable(4.51x)
one or more required annual facts are missing
Current ratio4.45x[7-8]2.96x41.18392026-03-31
Growth and financing
Revenue growth, three-year compoundnot computable10.0%
four annual observations are required; found 3
Free cash flow growth, three-year compoundnot computable10.9%
four consecutive annual FCF observations are required; found 2
Reinvestment ratenot computable37.1%
NOPAT must exceed $100,000
Asset growth, three yearsnot computable2.1%
four annual observations are required; found 3
Net share issuance, one yearnot computable2.5%
prior share count is 20 days earlier

Gross profitability. Revenue less cost of goods sold, over total assets.

Accruals ratio. Net income less operating cash flow, over average assets; lower is stronger.

Gross margin stability, five years. Standard deviation of gross margin; lower is stronger.

Twelve-month failure probability. CHS model; lower is stronger.

Net debt to EBITDA. Lower is stronger.

Net share issuance, one year. Split-adjusted; lower is stronger.

Among 371 Peers [top]

What the Price Implies [top]

Market measures at the 2026-10-08 close. None enters the grade. Percentile among graded peers with the same measure.

MeasureValuePeer medianPercentileReading
Twelve-month price change, skipping the latest month(78.7%)8.0%4hotter than 4 of 100 peers
Distance from 52-week high(88.2%)(31.4%)5closer to its high than 5 of 100 peers
EBIT to enterprise value(1,643.6%)(1.5%)1pricier than 99 of 100 peers
Free cash flow yield(404.4%)(1.0%)3pricier than 97 of 100 peers
Book value to price1.040.2887pricier than 13 of 100 peers
Sales to price0.000.310pricier than 100 of 100 peers
Composite equity issuance, five yearsnot computable20.3%a share count from five years earlier is required
Relative strength against the sector, log excess return(1.76)(0.14)4ahead of 4 of 100 peers

Inputs: market equity $3.0M; EBIT -$17.0M; free cash flow -$12.3M; book equity $3.2M; sales $0; debt $1.5M; cash $3.5M[13].

Diagnostics [top]

Diagnostics do not feed the grade.

Piotroski F-score: None of 9, period end 2026-03-31
Return on assets above zero(170.5%)✗ fail[4,6]
Operating cash flow above zero-$12.3M✗ fail[5]
Return on assets improved(49.2 pts)✗ fail[4,6,14-15]
Operating cash flow exceeds net income$4.4M✓ pass[4-5]
Long-term leverage felln/a[1,6,15]
Current ratio improved(118.3 pts)✗ fail[7-8,16-17]
No new shares issuedn/a[18-19]
Gross margin improvedn/a
Asset turnover improved0.0 pts✗ fail[2,6,15,20]
Cash, filings, liquidity
Cash and equivalents$3.5M[3]
Operating cash flow, four quarters-$13.2M[3,5,21-24]
Months of runway3.1
Late filings, two years0
NT 10-K or NT 10-Q
Days since last periodic filing57
10-Q received Aug 13, 2026
Median daily dollar volume$625,045
63 sessions
Days since newest grade input116

Downloads [top]

Sources [top]

Every citation on this page. Filing opens the SEC index page for that submission; viewer opens the SEC interactive data for the same filing; series opens the SEC XBRL API record for that tag and company.

#ConceptXBRL tagValuePeriod endReceivedFormLinks
1assetsus-gaap:Assets$7.6M2026-03-312026-05-2710-Kfiling · viewer · series
2revenueus-gaap:Revenues$02026-03-312026-05-2710-Kfiling · viewer · series
3cashus-gaap:CashAndCashEquivalentsAtCarryingValue$3.5M2026-06-302026-08-1310-Qfiling · viewer · series
4net incomeus-gaap:NetIncomeLoss-$16.7M2026-03-312026-05-2710-Kfiling · viewer · series
5operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$12.3M2026-03-312026-05-2710-Kfiling · viewer · series
6assetsus-gaap:Assets$9.8M2025-03-312026-05-2710-Kfiling · viewer · series
7current assetsus-gaap:AssetsCurrent$7.6M2026-03-312026-05-2710-Kfiling · viewer · series
8current liabilitiesus-gaap:LiabilitiesCurrent$1.7M2026-03-312026-05-2710-Kfiling · viewer · series
9retained earningsus-gaap:RetainedEarningsAccumulatedDeficit-$67.1M2026-03-312026-05-2710-Kfiling · viewer · series
10operating incomeus-gaap:OperatingIncomeLoss-$17.0M2026-03-312026-05-2710-Kfiling · viewer · series
11book equityus-gaap:StockholdersEquity$5.9M2026-03-312026-05-2710-Kfiling · viewer · series
12liabilitiesus-gaap:Liabilities$1.7M2026-03-312026-05-2710-Kfiling · viewer · series
13shares outstandingdei:EntityCommonStockSharesOutstanding971,0432026-08-062026-08-1310-Qfiling · viewer · series
14net incomeus-gaap:NetIncomeLoss-$11.4M2025-03-312026-05-2710-Kfiling · viewer · series
15assetsus-gaap:Assets$9.4M2024-03-312025-05-2910-Kfiling · viewer · series
16current assetsus-gaap:AssetsCurrent$9.6M2025-03-312026-05-2710-Kfiling · viewer · series
17current liabilitiesus-gaap:LiabilitiesCurrent$1.7M2025-03-312026-05-2710-Kfiling · viewer · series
18shares outstandingdei:EntityCommonStockSharesOutstanding11,409,3442026-06-102026-06-1510-K/Afiling · viewer · series
19shares outstandingdei:EntityCommonStockSharesOutstanding11,409,3442026-05-212026-05-2710-Kfiling · viewer · series
20revenueus-gaap:Revenues$02025-03-312026-05-2710-Kfiling · viewer · series
21operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$3.5M2026-06-302026-08-1310-Qfiling · viewer · series
22operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$9.4M2025-12-312026-02-1110-Qfiling · viewer · series
23operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$6.4M2025-09-302025-11-1210-Qfiling · viewer · series
24operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$2.6M2025-06-302026-08-1310-Qfiling · viewer · series

Limitations [top]

Peer group. Sector assignment from four-digit SIC codes, hand-tuned and published. The grade under three alternative peer policies is tabled above.

Size. Within a sector the letter tracks size. Among graded filers in the smallest asset band, 72% grade E and 0% grade A; in the largest, 13% grade E and 21% grade A. Universe as of Oct 9, 2026.

Failure model. filings 2012-01-01 to 2019-12-31 fit, filings 2020-01-01 to 2025-12-31 test; status post hoc pending confirmation. pre-registered on 2026 filings once their 12-month outcome windows close; supported if the paired per-quintile gain over the pooled model has a lower bound above 0.05.

Input validity. Revenue or total assets at or below $100,000 sets the degenerate-inputs flag. An input whose denominator is at or below $100,000 is left not computable rather than ranked.

Returns. No input on this page has a post-2015 confidence interval on returns that excludes zero. The grade ranks reported financial condition and is not a return forecast.